DJIA 18,214.42 -10.15 -0.06%
NASDAQ 4,987.89 20.75 0.42%
S&P 500 2,110.74 -3.12 -0.15%
market minute promo

Express Scripts (NASDAQ: ESRX)

company name or ticker
Company Photos
(Click to zoom)

Can Gilead Boost HCV Sales with Health Service Deals? - Analyst Blog

Gilead Sciences Offering Fresh Wave Of Competition To AbbVie's Viekira Pak

VUG, UPS, AGN, ESRX: Large Outflows Detected at ETF

Thornburg Value Fund Q4 2014 Commentary

AbbVie Inc. Earnings: After a Strong Year, Eyes Shift to 2015

AbbVie Inc's earnings report set the stage for 2015.

5 Things AbbVie Inc.'s Management Wants You to Know

How AbbVie is doing and what lies ahead -- straight from the company's executives.

My Well-Valued Growth Portfolio Beats The S&P 500 For January

How Regeneron Pharmaceuticals, Sanofi, And Amgen Will Weather The Inevitable Price Wars

What's Behind Gilead Sciences' Strong Q4 but Weak 2015 Outlook?

Gilead Sciences blows away Q4 expectations but underwhelms with its 2015 projections.

What to Expect From Gilead Earnings

See More Articles...